Background: Chagas disease, resulting from the protozoan Trypanosoma cruzi, is an
important cause of heart failure, stroke, arrhythmia, and sudden death. Traditionally …

The genetic diversity of Trypanosoma cruzi, the protozoan agent of Chagas disease, is
widely recognized. At present, T. cruzi is partitioned into seven discrete typing units (DTUs) …

Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately
one-third of people infected with the protozoan parasite Trypanosoma cruzi. One way T …

Background Benznidazole, a nitroimidazole derivative, has been recommended for the
treatment of acute and congenital Trypanosoma cruzi infection (Chagas' disease). We have …

A double-blind, randomized, clinical field trial was designed to test the efficacy and tolerance
of a specific drug treatment in children in the indeterminate phase of infection by …

Chagas disease caused by Trypanosoma cruzi remains an important neglected tropical
disease and a cause of significant morbidity and mortality. No longer confined to endemic …

Chagas disease, a chronic systemic parasitosis caused by the Kinetoplastid protozoon
Trypanosoma cruzi, is the first cause of cardiac morbidity and mortality in poor rural and …

The aim of this article is to present an investigation of cure rate, after long follow up, of
specific chemotherapy with benznidazole in patients with both acute and chronic Chagas …

The diagnostic and clinical aspects of congenital Chagas' disease were studied in 71
children in Buenos Aires. The children's ages ranged from 2 days to 10 years. In infants< 6 …

USE OF A SIMPLIFIED POLYMERASE CHAIN REACTION PROCEDURE TO DETECT
TRYPANOSOMA CRUZI IN BLOOD SAMPLES FROM CHRONIC CHAGASIC PATIE Page 1 Am. J …